Cambrex Inks Deal with Lilly to Support Biotech Collaborator Manufacturing
The Cambrex Longmont facility reportedly offers all services required to advance early-stage small molecules into the clinic.
Related Articles
Gene Therapy for Inherited Deafness Approaches a Threshold
Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to sustain momentum.
Boosting neuronal activity-driven mitochondrial DNA transcription improves cognition in aged mice
Deciphering the complex interplay between neuronal activity and mitochondrial function is pivotal in understanding brain aging, a multifaceted process marked by declines in synaptic function…
Trump names OSTP director as part of White House tech team
Michael Kratsios and Lynne Parker would reprise their roles in first Trump administration and work with AI czar
Japanese researchers surprised to learn they co-authored papers with North Korean scientists
Journalists identify papers that could violate U.N. ban on scientific ties with North Korea
Earth’s clouds are shrinking, boosting global warming
Narrowing storm bands may be a surprising and dangerous new feedback of climate change
Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses
The seasonal influenza vaccine contains strains of viruses from distinct subtypes that are grown independently and then combined. However, most individuals exhibit a more robust…
Feeling full? Researchers pinpoint neurons that prevent eating too much, too fast
Mouse study highlights neural circuits regulating the speed and amount of food intake
Early genome duplications in conifers and other seed plants
A new phylogenomic approach reveals that conifer genomes are duplicated despite rare polyploidy among extant species.
The nitroplast: A nitrogen-fixing organelle
A bacterial endosymbiont of marine algae evolved to an organelle
Antarctic video reveals deepest canyon on Earth
Study uncovers landscapes that will influence future ice melt